Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

A major scientific advance in protein modeling developed by Microsoft Research AI for Science, has been published in Science.

WEHI has formed a partnership with the Parkinson's Research Foundation with one clear goal: to intensify the search for drug treatments to stop ...

Conversations with entrepreneurs, technologists, and researchers on emerging technologies and the importance of STEM in drug ...

AI meets molecular dynamics in Divamics’ latest breakthroughs, accelerating new therapies for complex metabolic conditions.

Microsoft's CEO, Satya Nadella, has announced BioEmu-1, a new AI system designed to accelerate drug discovery by decoding ...

While AI-driven approaches tout increased speed and lower costs, commercial interests compromise scientific collaboration.

Drug discovery startup Synfini Inc. said today it has closed on an $8.9 million expansion funding round led by JSL Health ...

Satya Nadella has unveiled BioEmu, Microsoft's new AI initiative aimed at accelerating drug discovery processes.

A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI.

Drug discovery efforts based on DNA-encoded chemical libraries are inadvertently overlooking numerous potential drug ...

Scientists have discovered novel drug candidates which could ultimately lead to new effective treatments for conditions ...